Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

WGS

Live52w low +22.1%

Core line items from WGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: GeneDx Holdings Corp.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$427.54M	$305.45M	$202.57M	$234.69M
Operating Income	$-13.08M	$-23.21M	$-180.60M	$-667.65M
Net Income	$-21.02M	$-52.29M	$-175.77M	$-548.98M
EPS (Diluted)	$-0.73	$-1.94	$-7.23	$-53.63
Total Assets	$523.71M	$419.38M	$418.76M	$490.94M
Total Liabilities	$215.53M	$174.13M	$190.74M	$237.24M
Cash & Equivalents	$105.00M	$85.21M	$99.68M	$123.93M
Free Cash Flow OCF − CapEx	$14.26M	$-33.99M	$-185.40M	$-326.31M
Shares Outstanding	29.25M	28.02M	25.98M	11.77M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from WGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +22.1%

Entity: GeneDx Holdings Corp.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$427.54M	$305.45M	$202.57M	$234.69M
Operating Income	$-13.08M	$-23.21M	$-180.60M	$-667.65M
Net Income	$-21.02M	$-52.29M	$-175.77M	$-548.98M
EPS (Diluted)	$-0.73	$-1.94	$-7.23	$-53.63
Total Assets	$523.71M	$419.38M	$418.76M	$490.94M
Total Liabilities	$215.53M	$174.13M	$190.74M	$237.24M
Cash & Equivalents	$105.00M	$85.21M	$99.68M	$123.93M
Free Cash Flow OCF − CapEx	$14.26M	$-33.99M	$-185.40M	$-326.31M
Shares Outstanding	29.25M	28.02M	25.98M	11.77M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.